Duke Children’s provides lifelong, coordinated care for children with primary immunodeficiency disease. We have been designated a Jeffrey Modell Foundation Diagnostic and Research Center, and the Immune Deficiency Foundation has named us a Center of Excellence. These designations recognize us for:
- Providing the highest standard of care
- Using innovation to advance treatments for immune deficiencies
- Bringing groundbreaking clinical trials to our patients
We achieve this high level of care by providing services not available at other hospitals.
Specialized Lab Testing
Your child has access to specialized lab testing, which is used to diagnose different primary immune deficiency conditions.
Access to the Latest Research and Treatments
We’re actively involved in the latest research, including ways to improve the effectiveness of bone marrow/stem cell transplants. Children who come to Duke Children’s may have access to innovative treatment as clinical trial participants.
Research into Diagnosis and Treatment of Primary Immune Deficiency Disease
As part of the Primary Immune Deficiency Treatment Consortium, we’re one of 44 centers studying the diagnosis and treatment of infants and children born with primary immune deficiency diseases, with the overall goal to improve treatment of these conditions.
Treatment for Infants Born with SCID
Duke Children’s is one of 44 programs in the U.S. and Canada that treat infants born with severe combined immunodeficiency (SCID). We have achieved an overall survival rate of 75 percent for these infants using innovative bone marrow stem cell transplant therapies that do not require pre-transplant chemotherapy.
Thymus Transplant Program
We are also internationally recognized for our research-based thymus transplant program, which treats children with DiGeorge syndrome.
Education and Training of Experts
We train the next generation of doctors to be experts in diagnosing and treating immune deficiencies.